Systemic α₂-agonist use and lower hazard of glaucoma compared with β-blockers: a cohort study
{{output}}
Objective: Systemic antihypertensive medications may influence glaucoma-related outcomes through intraocular pressure-dependent and vascular mechanisms. While topical α₂-agonists are established glaucoma therapies, the associat... ...
